Abstract
Mitochondria receive calcium (Ca2+) signals from endoplasmic reticulum (ER) and decode them into pro-apoptotic inputs, which lead to cell death. Therefore, mitochondrial Ca2+ overload is considered a fundamental trigger of the apoptotic process, and several oncogenes and tumor suppressors modify the activity of protein involved in Ca2+ homeostasis to control apoptosis. The identification of the channel responsible for mitochondrial Ca2+ entry, the Mitochondrial Ca2+Uniporter (MCU), together with its regulatory components, MICU1 and MCUR1, provides new molecular tools to investigate this process. Recent data have also shown that miR-25 decreases mitochondrial Ca2+ uptake through selective MCU downregulation, conferring resistance to apoptotic challenges. MCU appears to be downregulated in human colon cancer samples, and accordingly, miR-25 is aberrantly expressed, indicating the importance of mitochondrial Ca2+ regulation in cancer cell survival.
Keywords: mitochondria, calcium (Ca2+), Mitochondrial Calcium Uniporter (MCU), MicroRNAs (MiRNA), apoptosis, cell death, cancer
In the last two years, the discovery of the pore-forming subunit of the mitochondrial Ca2+ uptake channel (Mitochondrial Calcium Uniporter, MCU)1,2 and its regulatory subunits, termed MICU1 (mitochondrial calcium uptake 1)3 and MCUR1 (mitochondrial calcium uniporter regulator 1),4 opened a new era for the study of mitochondrial Ca2+ regulation and its key role in a variety of processes, including cell death. In the presence of an apoptotic stimulus, mitochondria receive Ca2+-mediated inputs that induce the release of a number of pro-apoptotic factors from the mitochondria.5,6 Several oncogenes and tumor suppressors manipulate Ca2+ to exert their anti/pro-apoptotic activities. For example, Akt and Bcl-2 regulate ER Ca2+ flux to avoid mitochondrial Ca2+ overload and apoptosis;7,8 in contrast, pro-apoptotic genes, such as Fhit and PML, act at mitochondrial and ER levels, respectively, to promote mitochondrial Ca2+ accumulation.9,10 Although the connection between mitochondrial Ca2+ increase and apoptosis is widely accepted, the mechanistic role of mitochondrial Ca2+ homeostasis in tumorigenesis is not fully understood. MicroRNAs (miRNAs) are a class of naturally occurring small noncoding RNAs that are capable of regulating the expression of protein-coding genes at the posttranscriptional level, which consequently leads to a decrease in target protein abundance.11 Dysregulation of miRNA expression could lead to a variety of human disorders, including cancer.12 Thus, miRNAs may function as oncogenes or tumor suppressors. Among the oncogenic miRNAs, miR-25 is one of the most studied and well described. miR-25 is 22 nucleotides in length, hosted by the minichromosome maintenance protein-7 (MCM7) gene, and transcribed as part of the mir-106b~25 polycistron; it is overexpressed in several human cancers, including pediatric brain tumors,13 gastric adenocarcinoma,14 epidermal growth factor receptor-positive lung adenocarcinoma15 and prostate carcinoma16 and has been reported to target different regulators of the apoptotic pathway, such as BIM,17 PTEN16 and TRAIL.18 Mir-25 also affects Ca2+ homeostasis through the specific downregulation of MCU, causing a strong decrease in mitochondrial Ca2+ uptake and, importantly, conferring resistance to Ca2+-dependent apoptotic challenges.19 Prostate cancer cell lines, which exhibit high levels of miR-25, display very low amounts of MCU, and this inverse correlation (high miR-25/low MCU) is also maintained in colon cancer cell lines. Expression of miR-25 inhibitor in HCT116 cells increases mitochondrial Ca2+ levels and re-sensitizes cells to apoptosis. A cancer link has been established through the detection of high miR-25 levels in stage II and III colonic adenocarcinoma samples, whereas MCU is virtually undetectable by immunohistochemistry. Other members of the miR-25 family, such as miR-92a and miR-363, have the same effect on MCU expression and Ca2+ signaling as miR-25. These observations not only highlight the deep involvement of the whole family in the regulation of Ca2+ homeostasis, but also suggest how cancer cell survival, which is favored by MCU downregulation, might be ascribed to the upregulation of all miR-25 family members or strong expression of a singular miR, different from miR-25. Thus, both miR-25-5p, which is the different mature miR that originates from the opposite arm of the same pre-miRNA, and members of the same miRNA cluster, i.e., miR-106b, were predicted to target MCU mRNA, although their activity has not yet been tested. Therefore, the miR-106b~25 cluster might also play an important role in the control of MCU levels.
Regulation of intracellular Ca2+ levels by miRNAs might be considered a fundamental aspect in several physio-pathological conditions. In the Ca2+-dependent apoptosis context, which is characterized by sustained Ca2+ release from the ER and consequent accumulation at the mitochondrial level,20 the specific expression of miR-targeting mitochondrial Ca2+ effectors, such as miR-25, may be considered one of the most rapid intracellular mechanisms to prevent mitochondrial Ca2+ overload and avoid cell death. This process appears to be aberrantly overexpressed in tumors, especially in colon and prostate cancer cells.
Interplay between the modulation of Ca2+ levels and miRNAs has also been highlighted in other pathological scenarios. For example, in cardiomyocytes, loss of miR-133a–mediated IP3R II (inositol 1,4,5 trisphosphate receptor, the calcium channel within the membranes of sarco/endoplasmic Ca2+ stores) repression generates a positive feedback loop to drive the hypertrophic response, a process that is primarily Ca2+ dependent.21 In the same cellular setting, miR-214 protects the mouse heart from ischemic injury by controlling Ca2+ overload and cell death through the repression of the mRNA encoding sodium/calcium exchanger 1 (Ncx1), a key regulator of Ca2+ influx.22 Moreover, miR-708, which is transcriptionally repressed in metastatic breast cancer, targets the ER protein neuronatin to decrease intracellular calcium levels, resulting in decreased cell migration and impaired metastases.23
In conclusion, the interplay between intracellular Ca2+ and miRNAs might be a key aspect in several pathological conditions. Specifically, the suppression of mitochondrial Ca2+ entry by cancer-related miR-25 represents the first study of the control of the mitochondrial uniporter by miRNA19and offers initial clues to the relevance of this pathway in human cancers.
Acknowledgments
This research was supported bythe Italian Association for Cancer Research (AIRC), Telethon (GGP09128 and GGP11139B), the Italian Ministry of Education, University and Research and the Italian Ministry of Health to P.P. S.M. is supported by a FIRC fellowship.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were disclosed.
Footnotes
Previously published online: www.landesbioscience.com/journals/cib/article/23818
References
- 1.Baughman JM, Perocchi F, Girgis HS, Plovanich M, Belcher-Timme CA, Sancak Y, et al. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter. Nature. 2011;476:341–5. doi: 10.1038/nature10234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.De Stefani D, Raffaello A, Teardo E, Szabò I, Rizzuto R. A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter. Nature. 2011;476:336–40. doi: 10.1038/nature10230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Perocchi F, Gohil VM, Girgis HS, Bao XR, McCombs JE, Palmer AE, et al. MICU1 encodes a mitochondrial EF hand protein required for Ca(2+) uptake. Nature. 2010;467:291–6. doi: 10.1038/nature09358. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Mallilankaraman K, Cárdenas C, Doonan PJ, Chandramoorthy HC, Irrinki KM, Golenár T, et al. MCUR1 is an essential component of mitochondrial Ca2+ uptake that regulates cellular metabolism. Nat Cell Biol. 2012;14:1336–43. doi: 10.1038/ncb2622. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Giorgi C, Agnoletto C, Bononi A, Bonora M, De Marchi E, Marchi S, et al. Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion. 2012;12:77–85. doi: 10.1016/j.mito.2011.07.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Giorgi C, Baldassari F, Bononi A, Bonora M, De Marchi E, Marchi S, et al. Mitochondrial Ca(2+) and apoptosis. Cell Calcium. 2012;52:36–43. doi: 10.1016/j.ceca.2012.02.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Marchi S, Marinello M, Bononi A, Bonora M, Giorgi C, Rimessi A, et al. Selective modulation of subtype III IP₃R by Akt regulates ER Ca²⁺ release and apoptosis. Cell Death Dis. 2012;3:e304. doi: 10.1038/cddis.2012.45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Pinton P, Ferrari D, Magalhães P, Schulze-Osthoff K, Di Virgilio F, Pozzan T, et al. Reduced loading of intracellular Ca(2+) stores and downregulation of capacitative Ca(2+) influx in Bcl-2-overexpressing cells. J Cell Biol. 2000;148:857–62. doi: 10.1083/jcb.148.5.857. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Rimessi A, Marchi S, Fotino C, Romagnoli A, Huebner K, Croce CM, et al. Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc Natl Acad Sci USA. 2009;106:12753–8. doi: 10.1073/pnas.0906484106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Giorgi C, Ito K, Lin HK, Santangelo C, Wieckowski MR, Lebiedzinska M, et al. PML regulates apoptosis at endoplasmic reticulum by modulating calcium release. Science. 2010;330:1247–51. doi: 10.1126/science.1189157. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33. doi: 10.1016/j.cell.2009.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Iorio MV, Croce CM. MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med. 2012;4:143–59. doi: 10.1002/emmm.201100209. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Birks DK, Barton VN, Donson AM, Handler MH, Vibhakar R, Foreman NK. Survey of MicroRNA expression in pediatric brain tumors. Pediatr Blood Cancer. 2011;56:211–6. doi: 10.1002/pbc.22723. [DOI] [PubMed] [Google Scholar]
- 14.Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 2008;13:272–86. doi: 10.1016/j.ccr.2008.02.013. [DOI] [PubMed] [Google Scholar]
- 15.Dacic S, Kelly L, Shuai Y, Nikiforova MN. miRNA expression profiling of lung adenocarcinomas: correlation with mutational status. Mod Pathol. 2010;23:1577–82. doi: 10.1038/modpathol.2010.152. [DOI] [PubMed] [Google Scholar]
- 16.Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, et al. Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation. Sci Signal. 2010;3:ra29. doi: 10.1126/scisignal.2000594. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Zhang H, Zuo Z, Lu X, Wang L, Wang H, Zhu Z. MiR-25 regulates apoptosis by targeting Bim in human ovarian cancer. Oncol Rep. 2012;27:594–8. doi: 10.3892/or.2011.1530. [DOI] [PubMed] [Google Scholar]
- 18.Razumilava N, Bronk SF, Smoot RL, Fingas CD, Werneburg NW, Roberts LR, et al. miR-25 targets TNF-related apoptosis inducing ligand (TRAIL) death receptor-4 and promotes apoptosis resistance in cholangiocarcinoma. Hepatology. 2012;55:465–75. doi: 10.1002/hep.24698. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Marchi S, Lupini L, Patergnani S, Rimessi A, Missiroli S, Bonora M, et al. Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25. Curr Biol. 2013;23:58–63. doi: 10.1016/j.cub.2012.11.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Patergnani S, Suski JM, Agnoletto C, Bononi A, Bonora M, De Marchi E, et al. Calcium signaling around Mitochondria Associated Membranes (MAMs) Cell Commun Signal. 2011;9:19. doi: 10.1186/1478-811X-9-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Drawnel FM, Wachten D, Molkentin JD, Maillet M, Aronsen JM, Swift F, et al. Mutual antagonism between IP(3)RII and miRNA-133a regulates calcium signals and cardiac hypertrophy. J Cell Biol. 2012;199:783–98. doi: 10.1083/jcb.201111095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Aurora AB, Mahmoud AI, Luo X, Johnson BA, van Rooij E, Matsuzaki S, et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca²⁺ overload and cell death. J Clin Invest. 2012;122:1222–32. doi: 10.1172/JCI59327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Ryu S, McDonnell K, Choi H, Gao D, Hahn M, Joshi N, et al. Suppression of miRNA-708 by polycomb group promotes metastases by calcium-induced cell migration. Cancer Cell. 2013;23:63–76. doi: 10.1016/j.ccr.2012.11.019. [DOI] [PubMed] [Google Scholar]